MCID: HMP005
MIFTS: 54

Hemiplegia malady

Categories: Rare diseases, Neuronal diseases

Aliases & Classifications for Hemiplegia

About this section

Aliases & Descriptions for Hemiplegia:

Name: Hemiplegia 11 48 27 39 13
Postnatal Infantile Hemiplegia Nos 11
Infantile Hemiplegia Nos 11
 
Hemiplegia, Infantile 68
Infantile Hemiplegia 11

Classifications:



External Ids:

Disease Ontology11 DOID:10969
ICD9CM32 343.4
MeSH39 D006429
ICD1030 G81, G81.9

Summaries for Hemiplegia

About this section
MalaCards based summary: Hemiplegia, also known as postnatal infantile hemiplegia nos, is related to alternating hemiplegia of childhood and spastic hemiplegia, and has symptoms including hemiplegia, paralysis; cerebral, hemiplegic and spastic; hemiplegia, congenital or infantile. An important gene associated with Hemiplegia is ATP1A2 (ATPase Na+/K+ Transporting Subunit Alpha 2), and among its related pathways are Proximal tubule bicarbonate reclamation and Synaptic vesicle cycle. Affiliated tissues include brain, testes and bone, and related mouse phenotypes are muscle and nervous system.

Related Diseases for Hemiplegia

About this section

Diseases related to Hemiplegia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 163)
idRelated DiseaseScoreTop Affiliating Genes
1alternating hemiplegia of childhood31.4ATP1A2, ATP1A3, CACNA1A, CALCA, SLC1A3, SLC2A1
2spastic hemiplegia12.4
3alternating hemiplegia of childhood 212.1
4hemiplegia alterans11.9
5benign familial nocturnal alternating hemiplegia of childhood11.9
6epileptic hemiplegia11.8
7atp1a2-related alternating hemiplegia of childhood11.8
8atp1a3-related alternating hemiplegia of childhood11.8
9idiopathic hemiconvulsion-hemiplegia syndrome11.8
10porencephaly 111.3
11familial porencephaly11.1
12familial hemiplegic migraine11.1
13episodic ataxia11.1
14medial medullary syndrome11.0
15porencephaly 210.9
16brown-sequard syndrome10.9
17moyamoya 6 with achalasia10.7
18episodic ataxia, type 610.7
19moyamoya disease 510.7
20moyamoya disease 210.7
21moyamoya disease10.7
22spasticity10.5
23primary pigmented nodular adrenocortical disease10.5COL4A1, COL4A2
24retinal arteries, tortuosity of10.4COL4A1, COL4A2
25anosognosia10.3
26epilepsy10.3
27thyroid crisis10.3ATP1A2, ATP1A3
28cerebritis10.2
29sarcocystosis10.2ATP1A2, CACNA1A, SLC1A3
30neuropathy, hereditary sensory, type ib10.1ACTA2, GUCY1A3, RNF213
31laryngitis10.1
32double fingernail of fifth finger10.1SCN1A, SLC2A1
33juvenile absence epilepsy10.1ATP1A2, ATP1A3, SCN1A
34bone benign neoplasm10.1SLC2A1, TAC1
35hemangioblastoma10.0SLC2A1, TAC1
36herpes zoster10.0
37herpes zoster ophthalmicus10.0
38chromosome 8-derived supernumerary ring /marker9.9ATP1A2, CACNA1A, SCN1A
39surfactant dysfunction9.9ATP1A2, CACNA1A, SCN1A
40cerebral palsy9.9
41pelvic inflammatory disease9.9ATP1A2, CACNA1A, SCN1A
42hemiplegic migraine9.9
43dystonia9.9
44calpainopathy9.8CALCA, TAC1
45parathyroid transitional clear cell adenoma9.8BGLAP, CALCA
46nodular goiter9.8BGLAP, CALCA
47reflex sympathetic dystrophy9.8
48aphasia9.8
49encephalitis9.8
50capillariasis9.8BGLAP, CALCA

Graphical network of the top 20 diseases related to Hemiplegia:



Diseases related to hemiplegia

Symptoms & Phenotypes for Hemiplegia

About this section

UMLS symptoms related to Hemiplegia:


hemiplegia, paralysis; cerebral, hemiplegic, spastic; hemiplegia, congenital or infantile

MGI Mouse Phenotypes related to Hemiplegia according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.8ACTA2, ATP1A2, ATP1A3, CACNA1A, COL4A1, GUCY1A3
2MP:00036318.3ATP1A2, ATP1A3, CACNA1A, COL4A1, COL4A2, GUCY1A3
3MP:00053868.1ATP1A2, ATP1A3, CACNA1A, COL4A1, RNF213, SCN1A
4MP:00053917.9ACTA2, CACNA1A, COL4A1, COL4A2, GUCY1A3, SLC1A3
5MP:00053857.5ACTA2, ATP1A2, COL4A1, COL4A2, GUCY1A3, RNF213

Drugs & Therapeutics for Hemiplegia

About this section

Drugs for Hemiplegia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 64)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
AcetylcholineapprovedPhase 4, Phase 377651-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
2Neuromuscular AgentsPhase 4, Phase 31129
3Neurotransmitter AgentsPhase 4, Phase 3, Phase 117734
4onabotulinumtoxinAPhase 4, Phase 3626
5incobotulinumtoxinAPhase 4, Phase 3635
6Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 122776
7Cholinergic AgentsPhase 4, Phase 33846
8abobotulinumtoxinAPhase 4, Phase 3626
9Botulinum ToxinsPhase 4, Phase 3669
10Botulinum Toxins, Type APhase 4, Phase 3630
11GastrodiaNutraceuticalPhase 42
12
BenzocaineapprovedPhase 318921994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
13tannic acidapproved, NutraceuticalPhase 31892
14
Lidocaineapproved, vet_approvedPhase 21226137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
15
Triamcinoloneapproved, vet_approvedPhase 2482124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
 
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triatex
Tricortale
Triderm
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
16
MentholapprovedPhase 2, Phase 123532216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
17
Sodium oxybateapprovedPhase 1, Phase 238502-85-25360545
Synonyms:
4-Hydroxybuttersaeure natriumsalz
4-Hydroxybutyrate sodium
4-Hydroxybutyric acid monosodium salt
4-Hydroxybutyric acid sodium salt
502-85-2
ARONIS24196
Anetamin
BUTYRIC ACID, 4-HYDROXY-, SODIUM SALT
Butanoic acid, 4-hydroxy-, monosodium salt
Butanoic acid, 4-hydroxy-, sodium salt
Butanoic acid, 4-hydroxy-, sodium salt (1:1)
Butyric acid, 4-hydroxy-, monosodium salt
Butyric acid, 4-hydroxy-, monosodium salt (8CI)
C4H7O3.Na
CHEMBL1200682
CID10412
D05866
EB 27
EINECS 207-953-3
GHB
Gamma OH
H-4040
H3635_SIGMA
HMS2091E15
Hydroxybutyric acid monosodium salt
 
LS-48077
MolPort-001-766-711
MolPort-006-717-541
NSC 84223
Natrium 4-hydroxybutyrat
OR28769
Oxybate sodium
Sodium 4-hydroxybutyrate
Sodium Oxybate [USAN]
Sodium Oxybutyrate
Sodium gamma-hydroxybutyrate
Sodium gammahydroxybutyrate
Sodium oxybate
Sodium oxybate (USAN)
Sodium-4-hydroxybutyrate
Somsanit
UNII-7G33012534
WY 3478
WY-3478
Xyrem
Xyrem (TN)
gamma-Hydroxy sodium butyrate
gamma-Hydroxybutyrate sodium
gamma-Hydroxybutyrate sodium salt
gamma-Hydroxybutyric acid sodium salt
gamma-Hydroxybutyric acid, sodium salt
18
Glycerolexperimental, approvedPhase 222356-81-5753
Synonyms:
1,2,3-Trihydroxypropane
1,2,3-propanetriol
1,2,3-trihydroxypropane
Bulbold
Cristal
E 422
Emery 916
Glyceol Opthalgan
Glycerin
Glycerin, anhydrous
Glycerin,anhydrous
Glycerine
Glycerinum
 
Glyceritol
Glycerol
Glycyl alcohol
Glyrol
Glysanin
IFP
Incorporation factor
Mackstat H 66
Monoctanoin component D
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Trihydroxypropane
Tryhydroxypropane
19Sodium Channel BlockersPhase 21515
20Immunosuppressive AgentsPhase 212770
21Triamcinolone diacetatePhase 2482
22Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 212767
23triamcinolone acetonidePhase 2482
24Triamcinolone hexacetonidePhase 2482
25Anti-Arrhythmia AgentsPhase 22969
26Anesthetics, LocalPhase 23272
27HormonesPhase 213979
28Carbon fiberPhase 1, Phase 212
29Anti-Inflammatory AgentsPhase 210355
30Central Nervous System DepressantsPhase 2, Phase 112806
31Hormone AntagonistsPhase 212778
32glucocorticoidsPhase 24920
33Diuretics, Potassium SparingPhase 21827
34AnestheticsPhase 2, Phase 19001
35Adjuvants, AnesthesiaPhase 1, Phase 21588
36Anesthetics, GeneralPhase 1, Phase 22787
37Anesthetics, IntravenousPhase 1, Phase 22406
38Protective AgentsPhase 27190
39
Methamphetamineapproved, illicitPhase 1232537-46-210836
Synonyms:
(+ )-Methylamphetamine
(+ )-methylamphetamine
(+)-(S)-Deoxyephedrine
(+)-(S)-N-alpha-Dimethylphenethylamine
(+)-(S)-N-alpha-dimethylphenethylamine
(+)-(S)-N-α-dimethylphenethylamine
(+)-(S)-deoxyephedrine
(+)-(s)-deoxyephedrine
(+)-(s)-n-alpha-dimethylphenethylamine
(+)-2-(N-Methylamino)-1-phenylpropane
(+)-Methylamphetamine
(+)-N,alpha-Dimethyl-beta-phenylethylamine
(+)-N,alpha-Dimethylphenethylamine
(+)-N,alpha-dimethyl-beta-phenylethylamine
(+)-N,alpha-dimethylphenethylamine
(+)-N-Methylamphetamine
(+)-N-methylamphetamine
(+)-methamphetamine
(+)-methylamphetamine
(+)-n,alpha-dimethyl-beta-phenylethylamine
(+)-n,alpha-dimethylphenethylamine
(+)-n-methylamphetamine
(2S)-N-methyl-1-phenylpropan-2-amine
(AlphaS)-N,alpha-dimethylbenzeneethanamine
(S)-(+)-Deoxyephedrine
(S)-(+)-Methamphetamine
(S)-(+)-N,alpha,dimethylphenethylamine
(S)-(+)-deoxyephedrine
(S)-(+)-methamphetamine
(S)-Methamphetamine
(S)-Methylamphetamine
(S)-N,alpha-Dimethylbenzeneethanamine
(S)-N,alpha-Dimethylbenzeneethanoamine
(S)-N,alpha-dimethylbenzeneethanamine
(S)-N,alpha-dimethylbenzeneethanoamine
(S)-N,α-dimethylbenzeneethanamine
(S)-methamphetamine
(S)-methylamphetamine
(alphaS)-N,alpha-dimethylbenzeneethanamine
(s)-(+)-deoxyephedrine
(s)-(+)-methamphetamine
(s)-(+)-n,alpha,dimethylphenethylamine
(s)-methamphetamine
(s)-methylamphetamine
(s)-n,alpha-dimethylbenzeneethanamine
(s)-n,alpha-dimethylbenzeneethanoamine
(αS)-N,α-dimethylbenzeneethanamine
1-Phenyl-2-methylamino-propan
1-Phenyl-2-methylamino-propan [German]
1-Phenyl-2-methylaminopropane
139-47-9
14611-50-8
1690-86-4
2S-(+)-Methamphetamine
45952-89-4
537-46-2
AC1L1W1Z
AC1Q4SVR
B40
Benzeneethanamine, N,alpha-dimethyl-, (S)- (9CI)
Benzeneethanamine, N,alpha-dimethyl-, (alphaS)- (9CI)
C07164
C10H15N
CHEBI:6809
CHEMBL1201201
CID10836
Crank
Crank [Street Name]
Crystal Meth
Crystal Meth [Street Name]
D-(S)-Methamphetamine
D-(s)-methamphetamine
D-1-Phenyl-2-methylaminopropan
D-1-Phenyl-2-methylaminopropan [German]
D-1-Phenyl-2-methylaminopropane
D-Deoxyephedrine
D-Desoxyephedrine
D-Methamphetamine
D-Methylamphetamine
D-N,alpha-Dimethylphenethylamine
D-N,alpha-dimethylphenethylamine
D-N-Methylamphetamine
D-Phenylisopropylmethylamine
D-deoxyephedrine
D-desoxyephedrine
D-methamphetamine
D-methylamphetamine
 
D-n,alpha-dimethylphenethylamine
D-n-methylamphetamine
D-phenylisopropylmethylamine
D08187
DB01577
DEA No. 1105
Desoxyephedrine hydrochloride
Desoxyn
Desyphed
Desyphed hydrochloride
Dextromethamphetamine
EINECS 208-668-7
HSDB 3359
ICE [Street Name]
Ice
L-Methamphetamine
L-methamphetamine
LS-103331
METHAMPHETAMINE
Metamfetamina
Metamfetamina [INN-Spanish]
Metamfetamina [inn-spanish]
Metamfetamine
Metamfetamine (INN)
Metamfetamine [INN]
Metamfetamine-m
Metamfetaminum
Metamfetaminum [INN-Latin]
Metamfetaminum [Latin]
Metamfetaminum [inn-latin]
Metamphetamine
Metanfetamina
Metanfetamina [INN-Spanish]
Metanfetamina [Spanish]
Metanfetamina [inn-spanish]
Meth
Meth (Street Name)
Methamphetamine
Methamphetamine, its salts, isomers, and salts of its isomers
Methamphetaminum
Methamphetaminum [INN-Latin]
Methamphetaminum [JP]
Methamphetaminum [inn-latin]
Methyl-.beta.-phenylisopropylamine
Methyl-beta-phenylisopropylamine
Methylamphetamine
MolPort-001-794-405
Métamfétamine
N-Methyl-1-phenyl-2-propanamine
N-Methyl-beta-phenylisopropylamin
N-Methyl-beta-phenylisopropylamin [German]
N-Methyl-beta-phenylisopropylamin [german]
N-Methyl-beta-phenylisopropylamine
N-Methylamphetamine
N-methyl-beta-phenylisopropylamin [german]
N-methyl-beta-phenylisopropylamine
N-methylamphetamine
NSC 25115
NSC25115
Norodin
PDSP1_001404
PDSP1_001405
PDSP2_001388
PDSP2_001389
Phenethylamine, N,alpha-dimethyl-, (S)-(+)- (8CI)
S-(+)-Methamphetamine
S-(+)-methamphetamine
Speed
Speed [Street Name]
Stimulex
UNII-44RAL3456C
WLN: 1MY1&1R -D
d-(S)-Methamphetamine
d-1-Phenyl-2-methylaminopropan [German]
d-1-phenyl-2-methylaminopropane
d-Deoxyephedrine
d-Desoxyephedrine
d-Methamphetamine
d-Methylamphetamine
d-N,.alpha.-Dimethylphenethylamine
d-N-Methylamphetamine
d-N-methylamphetamine
d-Phenylisopropylmethylamine
d-deoxyephedrine
d-desoxyephedrine
d-phenylisopropylmethylamine
desohyephedrine
methyl-β-phenylisopropylamine
40
DopamineapprovedPhase 1375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
41Neurotransmitter Uptake InhibitorsPhase 13464
42Dopamine AgentsPhase 13759
43Dopamine Uptake InhibitorsPhase 11305
44Adrenergic AgentsPhase 15140
45Autonomic AgentsPhase 19774
46Central Nervous System StimulantsPhase 12132
47
Fluoxetineapproved, vet_approved23554910-89-33386
Synonyms:
(+) or (-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine
(+) or (-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine
(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
(+/-)-Fluoxetine
(+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine
(+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine
(+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine
(+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine]
(+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine
3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine
52341-67-0
54910-89-3
57226-07-0
59333-67-4 (hydrochloride)
AB00053774
AC-14564
AC1L1FTH
AKOS003663021
Adofen
Animex-On
BPBio1_000354
BPBio1_000509
BRD-A31159102-001-01-9
BRD-A31159102-003-05-6
BSPBio_000461
BSPBio_003375
Bio-0787
Biomol-NT_000152
C17H18F3NO
CHEBI:5118
CHEMBL41
CID3386
D00326
DB00472
Deprex
DivK1c_006819
Eufor
Floxetine
Fluctin
Fluoxeren
Fluoxetin
Fluoxetina
Fluoxetina [INN-Spanish]
Fluoxetina [Spanish]
Fluoxetine (TN)
Fluoxetine (USAN/INN)
Fluoxetine Hcl
Fluoxetine Hydrochloride
Fluoxetine [USAN:INN:BAN]
Fluoxetinum
 
Fluoxetinum [INN-Latin]
Fluoxétine
Fluval
Fontex
Foxetin
HMS2090H14
KBio1_001763
KBio2_002159
KBio2_004727
KBio2_007295
KBio3_002595
KBioGR_001166
KBioSS_002159
L000931
LS-31040
Lilly-110140
Lopac0_000558
Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine
Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine
MolPort-001-683-482
N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine
N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine
NCGC00015428-10
NCGC00024879-03
NCGC00024879-04
NSC283480
Portal
Prestwick0_000511
Prestwick1_000511
Prestwick2_000511
Prestwick3_000511
Prozac
Prozac Weekly
Pulvules
Reconcile
Reneuron
SPBio_001815
SPBio_002382
STK734483
Sarafem
SpecPlus_000723
Spectrum2_001658
Spectrum3_001648
Spectrum4_000613
Spectrum5_001518
Spectrum_001679
TL8003595
UNII-01K63SUP8D
dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine
fluoxetine
fluoxetine (Prozac)
nchembio.534-comp2
48
Flumazenilapproved2678755-81-43373
Synonyms:
4H-Imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester
78755-81-4
8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester
AC-6846
AC1L1FSE
AC1Q33UE
Anexate
BIDD:GT0766
BPBio1_001190
BRD-K98769987-001-01-3
BRN 4763661
Biomol-NT_000285
C07825
C15H14FN3O3
CHEBI:5103
CHEMBL407
CID3373
CPD000058450
D005442
D00697
DB01205
EU-0100506
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5-methyl-5,6-dihydro-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
F 6300
F6300_SIGMA
Flumazenil (JAN/USP/INN)
Flumazenil [USAN:BAN:INN]
Flumazenilo
Flumazenilo [Spanish]
Flumazenilum
Flumazenilum [Latin]
Flumazepil
Flumazepil, Ro 15-1788, Anexate, Lanexat, Mazicon, Roma,Flumazenil
HMS2051D17
HMS2089B15
Hoffman La Roche Brand of Flumazenil
Hoffman-La Roche Brand of Flumazenil
I01-0379
LS-77778
 
Lanexat
Lopac-F-6300
Lopac0_000506
MLS000028850
MLS000759529
MLS001076354
Mazicon
MolPort-003-666-855
NCGC00015439-01
NCGC00015439-03
NCGC00015439-07
NCGC00025116-01
NCGC00025116-02
NCGC00025116-03
NCGC00025116-04
NCGC00025116-05
PDSP1_001778
PDSP2_001761
RO-151788
Ro 15 1788
Ro 15-1788
Ro 151788
Ro-15-1788
Ro-?15-1788
Ro15-1788
Roche Brand of Flumazenil
Romazicon
Romazicon (TN)
S1332_Selleck
SAM001246763
SBB063113
SMR000058450
TL8005362
Tocris-1328
UNII-40P7XK9392
UPCMLD-DP137
UPCMLD-DP137:001
ZINC00001464
[3H]Ro15-1788
ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
flumazenil
nchembio747-comp37
49Analgesics11287
50Psychotropic Drugs6279

Interventional clinical trials:

(show top 50)    (show all 174)
idNameStatusNCT IDPhase
1Functional Electrical Stimulation (FES) Assisted Walking: Enhancement of Walking Function After StrokeUnknown statusNCT00552916Phase 4
2Gastrodin Prevents Cognitive Decline Related to Cardiopulmonary BypassUnknown statusNCT00297245Phase 4
3A Randomized Double Blind Placebo Control Study of Huang-Chi-Wu-Wu- Tang in Patients With Intracranial Arterial StenosisUnknown statusNCT01553643Phase 4
4The Efficacy and Safety of MEDITOXIN® in Children With Cerebral PalsyUnknown statusNCT01256021Phase 4
5Τhe Effectiveness of Hydrotherapy Exercises on the Rehabilitation of Hemiplegic PatientsCompletedNCT01460277Phase 4
6Randomised, Evaluation-blinded, Crossover, Controlled Study Assessing Dynamic Hand Splinting in Adults With Post-stroke Hemiplegia (Orthox)RecruitingNCT02888548Phase 4
7Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)Not yet recruitingNCT02969356Phase 4
8The Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity on Impairment and Activity Limitation in Patients With Spastic Hemiparesis Following StrokeNot yet recruitingNCT02944929Phase 4
9HEMITOX : Effect of Botulinum Toxin Injections on Motor and Functional Ability of Upper Limb in Adults at Earlier Phases of Spastic Hemiplegia After StrokeUnknown statusNCT00276185Phase 3
10Mental Practice Efficacy in Stroke-Induced HemiparesisUnknown statusNCT01026896Phase 2, Phase 3
11Modulation of Brain Plasticity After Perinatal StrokeUnknown statusNCT01189058Phase 2, Phase 3
12MEOPA to Improve Physical Therapy Results After Multilevel SurgeryCompletedNCT00632528Phase 3
13Assisted Movement Neuro-rehabilitation: VA Multi-site Clinical TrialCompletedNCT00223808Phase 3
14Static and Dynamic Postural Stability in Cerebral Palsy ChildrenCompletedNCT01799304Phase 3
15Phase III Clinical Trial of "Botulax®" to Treat Children With Cerebral PalsyCompletedNCT01787344Phase 3
16Home Based Adaptive Arm Training for ChildrenNot yet recruitingNCT02751502Phase 3
17Ventilatory Muscle Training in StrokeNot yet recruitingNCT02828943Phase 3
18Effects of the Quantity of Repetitive Transcranial Magnetic Stimulation(rTMS) on the Recovery After StrokeTerminatedNCT01311271Phase 2, Phase 3
19Bimanual Training in Children With HemiplegiaUnknown statusNCT01413594Phase 1, Phase 2
20Bimanual Training in Children With Hemiplegia With Lower Limb and Postural Stimulation (HABIT & Leg)Unknown statusNCT01700777Phase 1, Phase 2
21Rehabilitation of Early Stroke Patients Using an AFO: an RCTUnknown statusNCT01006772Phase 1, Phase 2
22Use of Tendon Vibration and Mirror for the Improvement of Upper Limb Function and Pain ReductionUnknown statusNCT01010607Phase 1, Phase 2
23The Middle East "Stepping Forward" Project (MESF)Unknown statusNCT01466296Phase 2
24mCIMT and Eye Patching for Neglect Rehabilitation Post Stroke: A Longitudinal Study of Separate and Combined EffectsUnknown statusNCT00253825Phase 1, Phase 2
25Automatic Versus Intentional Movement Exercises to Enhance Arm Functions After StrokeUnknown statusNCT01565044Phase 2
26Subacromial Corticosteroid Injection for Hemiplegic Shoulder PainUnknown statusNCT00597766Phase 2
27Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO)CompletedNCT00931164Phase 1, Phase 2
28Electrical Stimulation for Recovery of Hand Function in Chronic Stroke SurvivorsCompletedNCT00891319Phase 2
29Low Intensity Physical Activity Leads to Improvement in Brachial-ankle Pulse Wave Velocity of HemiplegicsCompletedNCT01569386Phase 2
30Falls-based Training for Walking Post-StrokeCompletedNCT02787759Phase 2
31Functional Electrical Stimulation for Footdrop in HemiparesisCompletedNCT00148343Phase 2
32Training the Arm and Hand After Stroke Using Auditory Rhythm CuesCompletedNCT00523523Phase 1, Phase 2
33Post Stroke Hand Functions: Bilateral Movements and Electrical Stimulation TreatmentsCompletedNCT00369668Phase 2
34Contrastim Stroke TrialCompletedNCT01049802Phase 1, Phase 2
35Treatments for Recovery of Hand Function in Acute Stroke SurvivorsCompletedNCT00565045Phase 1, Phase 2
36FNS and Weight Support Treadmill Training for Gait Component RestorationCompletedNCT00011596Phase 2
37The Influence of MCIMT (Modified Constrained Induced Movement Therapy), Bilateral Intensive Treatment, and NDT Approach on the UL Function in Children With Hemiplegic Cerebral PalsyCompletedNCT00619853Phase 2
38Robot Assisted Upper Limb Neuro-RehabilitationCompletedNCT00011583Phase 2
39SSNB in Hemiplegic Shoulder PainCompletedNCT00732589Phase 2
40Video-Based Functional Performance and Assessment Following StrokeCompletedNCT00013494Phase 2
41Percutaneous Recanalization in Ischemic Stroke Management (PRIISM): A Feasibility Clinical StudyCompletedNCT00810095Phase 2
42Pilot Study, Comparative, Single-center, Randomized, Crossover, Double-blind, Against Placebo, Testing the Effectiveness of Triheptanoin Oil in Alternating Hemiplegia of ChildhoodRecruitingNCT02408354Phase 2
43Contralaterally Controlled FES of Arm & Hand for Subacute Stroke RehabilitationRecruitingNCT01688856Phase 2
44Combined Constraint Therapy and Bimanual Therapy for Children With Unilateral Brain InjuryRecruitingNCT02840643Phase 1, Phase 2
45E-Rehabilitation: Aerobic Resistance Training for Stroke SurvivorsRecruitingNCT02938000Phase 1, Phase 2
46Effects of Upper Extremity Rehabilitation Using Smart Glove in Stroke PatientsRecruitingNCT02592759Phase 2
47Study of HC-58 in Upper Limb Hemiplegic Patients After StrokeActive, not recruitingNCT01623622Phase 2
48Passive Mobilisation of Region of Shoulder Joints for Hemiplegic PatientNot yet recruitingNCT02904148Phase 2
49Constraint-induced Movement Therapy (CIMT) and Bimanual Training (HABIT) in Children With Hemiplegic Cerebral PalsyUnknown statusNCT00305006Phase 1
50Functional Electrical Stimulation Mediated Neuroplasticity: Lower Extremity CCNMES in StrokeUnknown statusNCT02199795Phase 1

Search NIH Clinical Center for Hemiplegia


Cochrane evidence based reviews: hemiplegia

Genetic Tests for Hemiplegia

About this section

Genetic tests related to Hemiplegia:

id Genetic test Affiliating Genes
1 Hemiplegia27

Anatomical Context for Hemiplegia

About this section

MalaCards organs/tissues related to Hemiplegia:

36
Brain, Testes, Bone, Eye, Cortex, Skin, Spinal cord

Publications for Hemiplegia

About this section

Articles related to Hemiplegia:

(show top 50)    (show all 776)
idTitleAuthorsYear
1
Infantile Hemiplegia. Cerebral Angioma. Subarachnoid HA (20916165)
morrhage.
2
Neuronavigation-assisted aspiration and electro-acupuncture for Hypertensive Putaminal Hemorrhage -a suitable technique on hemiplegia rehabilitation. (27593801)
2016
3
The Influence of Rocker Bar Ankle Foot Orthosis on Gait in Patients with Chronic Hemiplegia. (27265095)
2016
4
The effects of neuromuscular facilitation techniques on osteoporosis of hemiplegia limbs and serum leptin level in patients or rats with cerebral infarction. (26963737)
2016
5
Recognizable facial features in patients with alternating hemiplegia of childhood. (27312461)
2016
6
Hyperintense lesion along the pyramidal tract on DWI in hypoglycaemic hemiplegia. (27060077)
2016
7
New portable voice guidance device for the manual wheelchair transfer: a pilot study in patients with hemiplegia. (27049622)
2016
8
From intention to perception: The case of anosognosia for hemiplegia. (26969375)
2016
9
Efficacy of two injection-site localisation techniques for botulinum toxin injections: a single-blind, crossover, randomised trial protocol among adults with hemiplegia due to stroke. (27852706)
2016
10
De novo p.Arg756Cys mutation of ATP1A3 causes an atypical form of alternating hemiplegia of childhood with prolonged paralysis and choreoathetosis. (27634470)
2016
11
Acute mental change and hemiplegia after autologous fat injection. (27352047)
2016
12
Effects of shoulder reaching exercise on the balance of patients with hemiplegia after stroke. (27512286)
2016
13
Reliability and validity of the Korean version of the community balance and mobility scale in patients with hemiplegia after stroke. (27630420)
2016
14
Individual joint contribution to body weight support in the affected lower limb during walking in post-stroke hemiplegia. (27690285)
2016
15
Efficacy of Upper Extremity Robotic Therapy in Subacute Poststroke Hemiplegia: An Exploratory Randomized Trial. (27006452)
2016
16
An unusual cause of hemiplegia post-percutaneous coronary intervention. (27828736)
2016
17
Does unilateral single-event multilevel surgery improve gait in children with spastic hemiplegia? A retrospective analysis of a long-term follow-up. (27907872)
2016
18
Effects of Home-based Telesupervising Rehabilitation on Physical Function for Stroke Survivors with Hemiplegia: A Randomized Controlled Trial. (27386808)
2016
19
Hemiconvulsion-hemiplegia syndrome. (27625282)
2016
20
Comparison of the Effect of Lateral and Backward Walking Training on Walking Function in Patients with Poststroke Hemiplegia: A Pilot Randomized Controlled Trial. (27323323)
2016
21
A case report of hemiplegia - Neurological sequelae of cerebral malaria. (27728385)
2016
22
Effects of Kinesio taping and Mcconnell taping on balance and walking speed of hemiplegia patients. (27190448)
2016
23
Effects of concentric and eccentric control exercise on gross motor function and balance ability of paretic leg in children with spastic hemiplegia. (27512281)
2016
24
Quantitative assessment of retropulsion of the hip, excessive hip external rotation, and excessive lateral shift of the trunk over the unaffected side in hemiplegia using three-dimensional treadmill gait analysis. (27077992)
2016
25
CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 13-2016. A 49-Year-Old Woman with Sudden Hemiplegia and Aphasia during a Transatlantic Flight. (27119240)
2016
26
Relation between muscle fiber conduction velocity and exerted dynamic characteristics of muscular tension in patients with hemiplegia caused by stroke. (27821946)
2016
27
Feasibility of Using an Arm Weight-Supported Training System to Improve Hand Function Skills in Children With Hemiplegia. (27767944)
2016
28
Treatment with Oral ATP decreases alternating hemiplegia of childhood with de novo ATP1A3 Mutation. (27146299)
2016
29
Hemiplegia Following Mild Head Injury in a Child with Sturge-Weber Syndrome - A Diagnostic Dilemma. (27539768)
2016
30
Structural and physiological muscle changes after post-stroke hemiplegia: A systematic review. (27677008)
2016
31
Hemiplegia following multiple bee sting. (27727866)
2016
32
Functional independence measure scores of patients with hemiplegia followed up at home and in university hospitals. (27065223)
2016
33
Alternating Hemiplegia of Childhood as a New Presentation of Adenylate Cyclase 5-Mutation-Associated Disease: A Report of Two Cases. (27931826)
2016
34
The effect of Monkey Chair and Band exercise system on shoulder range of motion and pain in post-stroke patients with hemiplegia. (27630403)
2016
35
Survival following decompressive hemicraniectomy for hemiconvulsion-hemiplegia-epilepsy syndrome: case report. (27176609)
2016
36
Spontaneously Fluctuating Motor Cortex Excitability in Alternating Hemiplegia of Childhood: A Transcranial Magnetic Stimulation Study. (26999520)
2016
37
Internal fixation versus conservative treatment for elderly patients with a trochanteric hip fracture in conjunction with post-stroke hemiplegia. (27445206)
2016
38
Alternating Hemiplegia with Ipsilateral Supranuclear Facial Palsy and Abducens Nerve Palsy Caused by Pontine Infarction. (27477418)
2016
39
EEG-Triggered Functional Electrical Stimulation Therapy for Restoring Upper Limb Function in Chronic Stroke with Severe Hemiplegia. (27882256)
2016
40
Effects of ankle plantar flexors stretching with closed kinetic chain on pelvic movements and gait speed in hemiplegia patients: a case study. (26957780)
2016
41
The effects of hand strength on upper extremity function and activities of daily living in stroke patients, with a focus on right hemiplegia. (27799695)
2016
42
Atrial myxoma: a rare cause of hemiplegia in children. (27942694)
2016
43
Evaluation of the Efficacy and Robustness of a Second Generation Implantable Stimulator in a Patient With Hemiplegia During 20 Years of Functional Electrical Stimulation of the Common Peroneal Nerve. (27121484)
2016
44
Influence of increased amount of exercise on improvements in walking ability of convalescent patients with post-stroke hemiplegia. (27065551)
2016
45
Hemiconvulsion-Hemiplegia-Epilepsy Syndrome. (28043687)
2016
46
Mentalizing the body: spatial and social cognition in anosognosia for hemiplegia. (26811254)
2016
47
A 55-Year-Old French Man With Sudden Hemiparesis and Hemiplegia. (26932935)
2016
48
Accuracy of non-paralytic anthropometric data for nutritional screening in older patients with stroke and hemiplegia. (27703163)
2016
49
A 55-Year-Old French Man With Sudden Hemiparesis and Hemiplegia. (26932936)
2016
50
Deficits in social behavioral tests in a mouse model of alternating hemiplegia of childhood. (27276195)
2016

Variations for Hemiplegia

About this section

Expression for genes affiliated with Hemiplegia

About this section
Search GEO for disease gene expression data for Hemiplegia.

Pathways for genes affiliated with Hemiplegia

About this section

GO Terms for genes affiliated with Hemiplegia

About this section

Cellular components related to Hemiplegia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1collagen type IV trimerGO:000558710.4COL4A1, COL4A2
2cell projectionGO:004299510.2BGLAP, CACNA1A, SLC1A3
3sodium:potassium-exchanging ATPase complexGO:000589010.0ATP1A2, ATP1A3
4axonGO:00304249.6ATP1A3, CALCA, SCN1A, TAC1
5neuronal cell bodyGO:00430258.9CACNA1A, CALCA, SCN1A, SLC1A3, TAC1

Biological processes related to Hemiplegia according to GeneCards Suite gene sharing:

(show all 17)
idNameGO IDScoreTop Affiliating Genes
1ATP hydrolysis coupled proton transportGO:001599110.6ATP1A2, ATP1A3
2cell communication by electrical coupling involved in cardiac conductionGO:008606410.6ATP1A2, ATP1A3
3cellular potassium ion homeostasisGO:003000710.6ATP1A2, ATP1A3
4cellular response to steroid hormone stimulusGO:007138310.6ATP1A2, ATP1A3
5cellular sodium ion homeostasisGO:000688310.6ATP1A2, ATP1A3
6establishment or maintenance of transmembrane electrochemical gradientGO:001024810.6ATP1A2, ATP1A3
7neurotransmitter uptakeGO:000150410.6ATP1A2, SLC1A3
8potassium ion importGO:001010710.6ATP1A2, ATP1A3
9response to glycosideGO:190341610.5ATP1A2, ATP1A3
10adult walking behaviorGO:000762810.5CACNA1A, SCN1A
11sodium ion export from cellGO:003637610.5ATP1A2, ATP1A3
12membrane depolarization during action potentialGO:008601010.5CACNA1A, SCN1A
13positive regulation of ossificationGO:004577810.1CALCA, TAC1
14positive regulation of cytosolic calcium ion concentrationGO:00072049.8CACNA1A, CALCA, TAC1
15response to painGO:00482659.8CACNA1A, CALCA, TAC1
16sodium ion transportGO:00068149.7ATP1A2, ATP1A3, SCN1A
17regulation of blood pressureGO:00082178.9ACTA2, ATP1A2, GUCY1A3, TAC1

Molecular functions related to Hemiplegia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1sodium ion bindingGO:003140210.2ATP1A2, SCN1A
2sodium:potassium-exchanging ATPase activityGO:000539110.1ATP1A2, ATP1A3
3steroid hormone bindingGO:199023910.0ATP1A2, ATP1A3

Sources for Hemiplegia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet